Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp. - common stock
(NQ:
PROF
)
6.115
-0.195 (-3.09%)
Delayed Quote
Updated: 1:11 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Profound Medical Corp. - common stock
< Previous
1
2
3
4
5
6
Next >
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
February 12, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
February 05, 2026
Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditions
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Upcoming Investor Events
January 27, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
January 15, 2026
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
January 12, 2026
Company’s year-end TULSA-PRO installed base stood at 78 systems; qualified sales pipeline grew to 97 new systems
From
Profound Medical Corp.
Via
GlobeNewswire
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 06, 2026
Profound Medical marks major milestone as the hospital launches its state-of-the-art iMRI suite to expand access to advanced prostate care
From
Profound Medical Corp.
Via
GlobeNewswire
InvestorNewsBreaks – Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) Closes $36 Million Registered Direct Offering
December 31, 2025
Via
Investor Brand Network
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Corp. Announces Upsize of Private Placement
December 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
December 23, 2025
Financing included participation by healthcare-dedicated investors alongside existing shareholders
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
December 19, 2025
Financing included participation by healthcare-dedicated investors alongside existing shareholders
From
Profound Medical Corp.
Via
GlobeNewswire
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 04, 2025
– CAPTAIN is the first randomized controlled trial ever comparing a new technology to the standard of care of robotic radical prostatectomy to successfully recruit to target –
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
November 11, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
November 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
October 16, 2025
Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
October 07, 2025
To release full third quarter 2025 financial results on November 13th; conference call to follow
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
August 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Posts Wider Loss in Q2
↗
August 14, 2025
Via
The Motley Fool
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
July 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
